DPP4i vs placebo
All‐cause mortality · CVD (ASCVD, HF, or both)
DPP4i showed no clear difference in all‐cause mortality compared with placebo (high certainty).
1 finding from 1 review
- Dipeptidyl peptidase‐4 inhibitors, glucagon‐like peptide 1 receptor agonists and sodium‐glucose co‐transporter‐2… 2021 · Cochrane Headline outcomes onlyOR 1.03 [0.96, 1.11]6 studies · 47968 participantsHigh